ExploreWatchlistsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Pretax margin (%)

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Market cap
$27.3B
P/E ratio
88.2x
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 20258.7-151.84%
Dec 31, 2024-16.8-29.21%
Dec 31, 2023-23.7-78.17%
Dec 31, 2022-108.6+7.63%
Dec 31, 2021-100.9-41.86%
Dec 31, 2020-173.6-56.91%
Dec 31, 2019-402.8-60.33%
Dec 31, 2018-1,015.5+2262.49%
Dec 31, 2010-43

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat